key: cord-0824315-9unvqa2p
authors: Duan, Zhihui; Duan, Qiong; Liu, Kun; Zhang, Xiaochong; Zhou, Shengyun; on behalf of Xingtai Society of Digestive Endoscopy,
title: Impact of the COVID-19 Pandemic on Acute Upper Gastrointestinal Bleeding in Xingtai City
date: 2021-03-06
journal: Gastroenterol Res Pract
DOI: 10.1155/2021/5586030
sha: b9a545f8f61bb48a1e131a6d63633b46659d941b
doc_id: 824315
cord_uid: 9unvqa2p

BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) has severely impacted the daily practice of gastrointestinal endoscopy worldwide. Most endoscopy centers in China were shut down in late January 2020. We investigated the impact of the shutdown on acute upper gastrointestinal bleeding (AUGIB) events in Xingtai City, Hebei Province, China. METHODS: A web-based survey collected information on gastroscopy workload and AUGIB events. The study period was from 4 weeks before to 4 weeks after lockdown initiation in Xingtai City. Fourteen public gastrointestinal endoscopy centers performing emergency endoscopies were contacted via e-mail to collect weekly emergency gastroscopy volumes and the number of AUGIB events. AUGIB was defined as recent melena, hematemesis, or both, with an endoscopically visible source of bleeding. RESULTS: Twelve (85.7%) of the 14 surveyed gastrointestinal endoscopy centers in the city- and county-level hospitals responded. Altogether, 4,045 and 1,077 gastroscopy procedures were performed 4 weeks before and after lockdown initiation (73.4% reduction), respectively. Peptic ulcer-related AUGIB and variceal AUGIB events showed a 58.5% and 52.9% decline, respectively, compared with pre-COVID-19 data. Although the absolute number of AUGIB events decreased during the pandemic (from 149 to 66), the likelihood of detecting AUGIB during gastroscopy increased (3.68% (pre-COVID-19 period) versus 6.13% (COVID-19 period); P < 0.05). CONCLUSION: The COVID-19 pandemic resulted in a considerable reduction in gastroscopy workload and AUGIB events; however, the likelihood of detecting AUGIB increased significantly during gastroscopies.

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rapidly spread from Wuhan to other provinces in China and worldwide [1, 2] . To curb its spread, a lockdown in Wuhan was initiated on January 23, 2020 [3] , which largely inhibited population migration from Wuhan. On January 27, 2020, the first confirmed case was reported in Xingtai City, Hebei Province [4] . Subsequently, many gastrointestinal endoscopy (GIE) centers were shut down for a mean period of 1 month after the Spring Festival Holi-day on February 1, 2020 [5] . The World Health Organization (WHO) declared COVID-19 as a global pandemic on March 11, 2020 [6] . Currently, this global pandemic has affected the daily practice of GIE and will continue to do so in the future. To prevent SARS-CoV-2 infection during endoscopic procedures, the international GIE societies have published several guidelines and position statements focused on endoscopy during the pandemic [7] [8] [9] . Sagami et al. recently confirmed that upper GIE is an aerosol-generating procedure [10] . Thus, as recommended by the established guidelines and statements, the deferment of elective endoscopies should be considered during the pandemic, and urgent endoscopies, such as those for acute gastrointestinal bleeding (GIB), should be performed by well-trained staff to minimize the risk of disease transmission [7] [8] [9] .

The lockdown has resulted in a large decline in acute upper GIB (AUGIB) events and endoscopy volumes [11, 12] . In Austria, the percentage of AUGIB events reduced by 40.7% during the 3 weeks of lockdown compared to the 3 weeks before lockdown [11] . Few studies on the impact of COVID-19 on AUGIB have been reported in China. We aimed to investigate how the lockdown might have influenced the UGIB events in Xingtai City, which has 7.39 million permanent residents and where the COVID-19 pandemic curve has been relatively flattened.

In this retrospective study, we developed a web-based survey using an Excel worksheet, which was sent to 14 GIE centers in Xingtai City to collect information on the weekly number of gastroscopy procedures performed in a specific center, as well as UGIB events and their cause from January 4, 2020, to February 28, 2020. We chose all the major city-and county-level GIE centers in Xingtai that responded to our survey successfully; those that responded with incomplete data were excluded. All the participating centers used a uniform tool to report the gastroscopy findings. The shutdown of GIE centers in Xingtai City started on February 1, 2020, and all the surveyed centers followed this policy. This study was approved by the Medical Ethical Review Board of Xingtai People's Hospital. Patients presenting with signs and symptoms of AUGIB (melena, hematemesis, or both, and decreased hemoglobin levels) were included in the study. UGIB are all those that also had an endoscopic finding explaining the symptoms. The data on the cause of UGIB was collected and analyzed. All responses were analyzed anonymously, so written informed consent was waived.

Adult patients presenting with AUGIB were admitted to the city-or county-level GIE centers in Xingtai City from January 4, 2020, to February 28, 2020. AUGIB was defined as evidence of hematemesis, coffee-ground emesis, or melena, with a 2 g/dL decline in hemoglobin. AUGIB was characterized according to its etiology and anatomical location. Patients with incomplete data or incomplete gastroscopy examination were excluded. Jan4-Jan10

Jan18-Jan24

Jan25-Jan31

Feb8-Feb14

Feb22-Feb28 

We contacted 14 city-and countylevel public hospitals in Xingtai City, Hebei Province, China. Twelve (85.7%) hospitals responded to our survey and provided the number of weekly esophagogastroduodenoscopy (EGD) procedures and AUGIB events, including variceal and peptic ulcer bleeding. Data on the number of EGD procedures performed in weeks 1-8 are shown in Figure 1 . During the study period, a dramatic decrease in the number of EGD procedures was observed since the COVID-19 outbreak. Overall, 4,045 EGD procedures were performed for AUGIB during the 4 weeks before the lockdown, which was higher than the number of EGD procedures performed during the 4 weeks after the lockdown (n = 1,077), with a 55.7% decline (from 149 to 66) in UGIB (P < 0:001) (Figure 2 ). During the 4-week lockdown period, the reduction rates of peptic and variceal UGIB were 58.5% (from 82 to 34) and 52.9% (from 34 to 16), respectively. Despite this, UGIB was diagnosed significantly more often in patients who had undergone EGD during the COVID-19 period compared to those who had undergone EGD during the pre-COVID-19 period (6.13% vs. 3.68%, P < 0:05, Table 1 ). During the COVID-19 period, peptic ulcer bleeding remained the main cause of UGIB (51.5%), followed by variceal bleeding (24.2%). The proportion of peptic ulcer disease (PUD) (from 55.0% to 51.5%) and variceal bleeding (from 22.8% to 24.2%) in UGIB remained almost equal between the two periods ( Figure 2 and Table 2 ).

Single Center. Figure 3 shows the gastroscopy volumes from January 4, 2020, to May 9, 2020, in Xingtai People's Hospital; a considerable decline was seen in the absolute volumes of gastroscopies performed during the lockdown (the period between the dashed vertical lines). After the partial relaxation of the restrictions during the lockdown on March 1, 2020, the gastroscopy volumes gradually increased; however, on May 9, the volumes remained lower than those observed in the same period in 2019.

The pandemic lockdown implemented by the Chinese government led to a massive reduction in gastroscopy volumes and UGIB events. Our data on the number of UGIB events in Xingtai City suggest that most bleeding cases must have been reported by the large public city-and county-level GIE centers. However, patients undergoing gastroscopy during the lockdown period were more likely to be diagnosed with UGIB. The volume of gastroscopy procedures showed a significant decline since the start of the lockdown, which is consistent with the findings of previous studies [11] [12] [13] [14] . This can be partially explained by the established guidelines' recommendation that elective endoscopic procedures should be delayed or canceled to minimize the risk of COVID-19 transmission [7] [8] [9] . Besides this, the public had concerns about seeking help during the lockdown. As expected, the number of UGIB events decreased from 149 to 66, showing a 55.7% reduction rate, which is similar to the rate reported in Austria (40.7%) [11] . The reasons for the decline in the UGIB events are currently unclear. One possible reason is that people are reluctant to seek medical care due to the fear of contracting COVID-19. Moreover, public transportation was suspended during the lockdown, thereby limiting patients' access to healthcare services. Furthermore, the screening procedures before endoscopy, such as chest computed tomography, temperature taking, use of epidemiological questionnaires, and COVID-19 polymerase chain reaction tests, when necessary, were very strict. Patients with negative screening results could undergo gastroscopy. Patients with relatively mild UGIB symptoms may have chosen not to visit GIE centers.

Moreover, gastroenterologists might choose to conservatively treat patients with UGIB to minimize the transmission risk for both patients and personnel. Over the same observation period, the number of variceal bleeding cases decreased by 52.9% (from 34 to 16) in our study, which was higher compared to that reported in Austria (10.8%; from 37 to 33) [11] . One interesting finding in our study was the increase in the percentage of patients diagnosed with UGIB during gastroscopies during the pandemic (from 3.68% to 6.13%). This echoed the findings by Lau et al., who reported that the percentage of patients receiving emergent endoscopies for UGIB during the pandemic increased from 30% to 38.9% (P < 0:001) [15] .

In the survey conducted in Austria [11] , variceal bleeding accounted for <10% of UGIB events and was not influenced by lockdown restrictions. However, in our study, variceal bleeding events constituted 24.2% of all UGIB events occurring during the pandemic, which was higher than 10%, but it was not affected by the lockdown restrictions (from 22.8% to 24.24%, P > 0:05). One possible reason might be that the patients with severe variceal bleeding requiring urgent interventions ultimately underwent EGD, whereas those with peptic ulcer bleeding who had less severe symptoms were more likely to be conservatively managed [14] . In a multicenter study, variceal upper gastrointestinal bleeding accounted for 14.6% during the COVID-19 pandemic, with 17% before the COVID-19 pandemic [16] . Certainly, the small sample size might have also influenced the result. 

In Northern Italy, the most common cause of UGIB was peptic ulcer disease [17] . This study has several limitations. First, the study's retrospective and multicenter design may have led to inconsistencies in determining UGIB cases. Second, data for the comparison of the gastroscopy volumes between the years 2019 and 2020 were only available from a single center, specifically Xingtai People's Hospital, which is one of the largest GIE centers in Xingtai City. Third, our study period, which was 4 weeks before and 4 weeks after the start of lockdown, was somewhat short. Fourth, the pandemic situation varies among different areas; thus, our findings only reflect immediate outcomes and cannot be generalized to other areas with different pandemic situations. A national survey with a larger sample size needs to be conducted in the future to clarify the impact of COVID-19 on endoscopy activity and AUGIB events. Fifth, we did not investigate the mortality rate of upper GIB because we did not collect the relevant data. Similarly, Schmiderer et al. [11] also did not investigate the mortality due to UGIB in the pandemic. However, one previous study has addressed the question. As Kim et al. [14] reported, inpatient mortality of GIB was similar between the pre-COVID-19 and COVID-19 periods.

In conclusion, the 4-week rigorous national lockdown significantly reduced the absolute gastroscopy volumes and AUGIB events in Xingtai City, Hebei Province, which may have a long-lasting impact on the practice of gastroscopy. We believe that our data will help GIE centers in managing their routine activities and AUGIB cases during and after the pandemic.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

First case of 2019 novel coronavirus in the United States

Distribution of the COVID-19 epidemic and correlation with population emigration from Wuhan, China

Control measures to prevent coronavirus disease 2019 pandemic in endoscopy centers: multi-center study

WHO Director-General's opening remarks at the media briefing on COVID-19-11

ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic

Coronavirus (COVID-19) outbreak: what the department of endoscopy should know

Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)

Aerosols produced by upper gastrointestinal endoscopy: a quantitative evaluation

Decline in acute upper gastrointestinal bleeding during COVID-19 5

Gastroenterology Research and Practice pandemic after initiation of lockdown in Austria

Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database

Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis

Effect of the Coronavirus 2019 Pandemic on Outcomes for Patients Admitted With Gastrointestinal Bleeding in

Collateral effect of coronavirus disease 2019 pandemic on hospitalizations and clinical outcomes in gastrointestinal and liver diseases: a territory-wide observational study in Hong Kong

The impact of covid-19 pandemic on urgent endoscopy in Italy: a nation-wide multicenter study

Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy

Data are available on reasonable request through 15131988129@163.com.

Written informed consent was waived because of its retrospective and anonymized data.

All authors declared that they have no conflict of interest.

Zhihui Duan designed the study, wrote the manuscript, and approved the final manuscript. Shengyun Zhou collected data, wrote the manuscript, and approved the final manu-script. Qiong Duan, Kun Liu, and Xiaochong Zhang collected and analyzed data and approved the final manuscript.

Supplementary Material contains the designed questionnaire which was sent to investigate endoscopy centers.(Supplementary Materials)